BRPI0921040A8 - sistemas transdérmicos contendo matrizes adesivas em multicamadas para modificar a liberação de fármacos - Google Patents

sistemas transdérmicos contendo matrizes adesivas em multicamadas para modificar a liberação de fármacos Download PDF

Info

Publication number
BRPI0921040A8
BRPI0921040A8 BRPI0921040A BRPI0921040A BRPI0921040A8 BR PI0921040 A8 BRPI0921040 A8 BR PI0921040A8 BR PI0921040 A BRPI0921040 A BR PI0921040A BR PI0921040 A BRPI0921040 A BR PI0921040A BR PI0921040 A8 BRPI0921040 A8 BR PI0921040A8
Authority
BR
Brazil
Prior art keywords
drug delivery
transdermal patches
layer adhesive
containing multi
patches containing
Prior art date
Application number
BRPI0921040A
Other languages
English (en)
Inventor
j miller ii Kenneth
Jackson Kristin
Original Assignee
Mylan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mylan Pharmaceuticals Inc filed Critical Mylan Pharmaceuticals Inc
Publication of BRPI0921040A2 publication Critical patent/BRPI0921040A2/pt
Publication of BRPI0921040A8 publication Critical patent/BRPI0921040A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00544—Plasters form or structure
    • A61F2013/00646—Medication patches, e.g. transcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00655—Plasters adhesive
    • A61F2013/0071—Plasters adhesive containing active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00902—Plasters containing means
    • A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0921040A 2008-11-17 2009-11-17 sistemas transdérmicos contendo matrizes adesivas em multicamadas para modificar a liberação de fármacos BRPI0921040A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/272,706 US9205062B2 (en) 2004-03-09 2008-11-17 Transdermal systems containing multilayer adhesive matrices to modify drug delivery
PCT/US2009/064804 WO2010057189A1 (en) 2008-11-17 2009-11-17 Transdermal systems containing multilayer adhesive matrices to modify drug delivery

Publications (2)

Publication Number Publication Date
BRPI0921040A2 BRPI0921040A2 (pt) 2015-12-29
BRPI0921040A8 true BRPI0921040A8 (pt) 2018-03-20

Family

ID=42170419

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921040A BRPI0921040A8 (pt) 2008-11-17 2009-11-17 sistemas transdérmicos contendo matrizes adesivas em multicamadas para modificar a liberação de fármacos

Country Status (10)

Country Link
US (2) US9205062B2 (pt)
EP (1) EP2373300A4 (pt)
JP (2) JP2012509276A (pt)
KR (1) KR101716909B1 (pt)
CN (1) CN102281874A (pt)
AU (1) AU2009313744A1 (pt)
BR (1) BRPI0921040A8 (pt)
CA (1) CA2743901A1 (pt)
MX (1) MX2011005183A (pt)
WO (1) WO2010057189A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3175780A1 (en) 2003-12-18 2017-06-07 Metronom Health, Inc. Implantable biosensor and methods of use thereof
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
WO2005102307A2 (en) 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
KR101643797B1 (ko) 2009-06-24 2016-07-28 스트러티직 사이언스 앤드 테크놀로지스, 엘엘씨 이부프로펜을 함유하는 국소 조성물
EP2295046B1 (de) * 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
CN102630160B (zh) * 2009-09-16 2014-05-07 株式会社三养生物制药 透皮递送系统、其制备方法以及使用所述系统的透皮递送方法
EP4491225A3 (en) 2010-12-29 2025-03-26 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
JP2014501283A (ja) * 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
EP3016641B1 (de) 2013-07-03 2018-09-05 LTS Lohmann Therapie-Systeme AG Transdermales therapeutisches system mit elektronischem bauteil
US9517981B2 (en) 2013-12-06 2016-12-13 Membrane Technology And Research, Inc. Membrane-based gas separation processes to separate dehydrogenation reaction products
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
EP3145502B1 (en) 2014-05-20 2022-07-06 LTS Lohmann Therapie-Systeme AG Transdermal delivery system containing rotigotine
US10695000B2 (en) 2015-09-02 2020-06-30 Metronom Health, Inc. Systems and methods for continuous health monitoring using an opto-enzymatic analyte sensor
CN108136230B (zh) 2015-10-22 2022-05-13 宝洁公司 发泡膜的阻隔贴片和改善皮肤外观的方法
CN108348788B (zh) 2015-10-22 2021-11-05 宝洁公司 发泡膜的阻隔贴片和改善皮肤外观的方法
ES2769286T3 (es) 2016-12-20 2020-06-25 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina
WO2018115010A1 (en) 2016-12-20 2018-06-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
US10857076B2 (en) * 2017-01-09 2020-12-08 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
EP3565641B1 (en) 2017-01-09 2021-06-23 The Procter & Gamble Company Barrier patch with soluble film and methods of improving skin appearance
US10751265B2 (en) 2017-01-09 2020-08-25 The Procter & Gamble Barrier patch with soluble film and methods of improving skin appearance
EP3641952B1 (en) 2017-06-22 2023-08-02 The Procter & Gamble Company Beauty care films including a water-soluble layer and a vapor-deposited coating
ES2881783T3 (es) 2017-06-26 2021-11-30 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polímero de acrílico y silicona
US10751266B2 (en) 2018-03-19 2020-08-25 The Procter & Gamble Company Method of making a barrier patch with soluble film
CN112533593A (zh) 2018-06-20 2021-03-19 罗曼治疗系统股份公司 含有阿塞那平的透皮治疗系统
CA3101420A1 (en) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
US20220087948A1 (en) * 2020-09-18 2022-03-24 Nanovibronix, Inc. Transdermal patch of a portable ultrasound-generating system for improved delivery of therapeutic agents and associated methods of treatment
USD999385S1 (en) 2021-10-18 2023-09-19 Dbv Technologies Patch assembly
USD999384S1 (en) 2021-10-18 2023-09-19 Dbv Technologies Patch assembly
KR102763965B1 (ko) * 2023-10-04 2025-02-05 신경연 피부 부착용 패치 및 이의 제조 방법
US12514756B1 (en) 2024-10-08 2026-01-06 Covidien Lp Dermal patch and systems, kits, and methods associated therewith
KR102908790B1 (ko) * 2025-07-03 2026-01-07 주식회사 에스티헬스케어 흡수 효과를 개선한 경피 약물 전달용 패치 및 이의 제조 방법

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286592A (en) 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS577413A (en) 1980-06-14 1982-01-14 Nitto Electric Ind Co Ltd Plaster
JPS5770816A (en) 1980-10-17 1982-05-01 Ono Pharmaceut Co Ltd Multilayered film preparation of prostagladin of prolonged action
DE3315272C2 (de) 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US4978535A (en) * 1984-07-30 1990-12-18 Ratcliff Perry A Method for cleaning contact lenses
US4883669A (en) 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
JPS61267510A (ja) 1985-05-20 1986-11-27 Nitto Electric Ind Co Ltd 外用医薬部材
USD296006S (en) 1985-06-20 1988-05-31 Ciba-Geigy Corporation Multicompartmentalized transdermal patch for administering drugs to the skin
US4666441A (en) 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
DE3775830D1 (de) 1986-06-13 1992-02-20 Alza Corp Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
US4938759A (en) 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
CH672888A5 (pt) 1986-11-07 1990-01-15 Mepha Ag
US4906463A (en) 1986-12-22 1990-03-06 Cygnus Research Corporation Transdermal drug-delivery composition
US4906169A (en) 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
JPH0818975B2 (ja) 1987-06-08 1996-02-28 日東電工株式会社 疾患治療用貼付剤
HU197519B (en) 1987-06-22 1989-04-28 Biogal Gyogyszergyar Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
DE3722775A1 (de) 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts Transdermales therapeutisches system
ZA885069B (en) 1987-07-24 1989-03-29 Fujisawa Pharmaceutical Co Sustained-release percutaneous preparations
KR960013236B1 (ko) * 1987-12-16 1996-10-02 리쳐서, 더 스테이트 유니버시티 오브 뉴저어지 에스트로겐/프로게스틴 경피 전달 장치 및 이를 포함하는 키트
US4915950A (en) 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US5300291A (en) 1988-03-04 1994-04-05 Noven Pharmaceuticals, Inc. Method and device for the release of drugs to the skin
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US4877618A (en) 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
DE3827561C1 (pt) 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US4882377A (en) 1988-09-21 1989-11-21 Dow Corning Corporation Low-viscosity pressure-adherent silicone elastomer compositions
DE3908432A1 (de) 1989-03-14 1990-09-27 Lohmann Therapie Syst Lts Pflaster als therapeutisches system zur verabreichung von wirkstoffen an die haut mit einer abgestuften wirkstoffabgabe, verfahren zu seiner herstellung sowie verwendung
DE3910543A1 (de) 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
US4978532A (en) 1989-08-11 1990-12-18 Pharmedic Co. Dosage form for administration of dehydroepiandrosterone
US5350581A (en) 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
EP0484543B1 (en) 1990-04-24 1995-12-13 Teijin Limited Plaster
IT1243745B (it) 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5300299A (en) 1991-07-22 1994-04-05 Dow Corning Corporation Silicone pressure sensitive adhesive containing alkylmethylsiloxane wax and related methods and devices
US5232702A (en) 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
JP2569396B2 (ja) 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
DE4316751C1 (de) 1993-05-19 1994-08-04 Lohmann Therapie Syst Lts Verfahren und Vorrichtung zur Herstellung eines transdermalen Therapiesystems zur Verabreichung von Wirkstoffen an die Haut in Form eines flächigen Mehrkammer- bzw. Mehrkammerkanalsystems
US5482988A (en) 1994-01-14 1996-01-09 Dow Corning Corporation Hot-melt silicone pressure sensitive adhesive with siloxylated polyether waxes as additives
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
ATE246909T1 (de) 1994-03-07 2003-08-15 Theratech Inc Medikament enthaltende, adhesive, zusammenbaubare,transdermale abgabevorrichtung
US5562917A (en) * 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
DE19629468A1 (de) 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
JP3802175B2 (ja) 1997-01-23 2006-07-26 角治 東條 経皮吸収治療用製剤の連続製造装置
AU1800099A (en) 1997-11-25 1999-06-15 Theratech, Inc. Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
US6337086B1 (en) 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
DE19940238A1 (de) 1999-08-25 2001-03-01 Lohmann Therapie Syst Lts Wirkstoffhaltiges therapeutisches System zur Applikation auf der Haut mit mindestens zwei polymerhaltigen Schichten
KR20010036685A (ko) 1999-10-11 2001-05-07 김윤 펜타닐을 함유하는 매트릭스형 경피투여제
WO2001030316A2 (en) 1999-10-28 2001-05-03 3M Innovative Properties Company Transdermal drug delivery devices comprising (r)-(z)-1-azabicyclo(2.2.1)heptan-3-one, 0-(3(3-methoxyphenyl)-2-propynyl)oxime
KR100758757B1 (ko) 1999-11-24 2007-09-14 애자일 쎄라퓨틱스, 인크. 개량된 경피적 피임제 송달시스템 및 송달방법
DE10042412B4 (de) 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
JP4358978B2 (ja) 2000-09-05 2009-11-04 日東電工株式会社 経皮吸収製剤
US20020119187A1 (en) 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20020187181A1 (en) 2001-05-14 2002-12-12 3M Innovative Properties Company System for delivering cosmetics and pharmaceuticals
JP2003104874A (ja) 2001-09-28 2003-04-09 Yuutoku Yakuhin Kogyo Kk 放出制御型薬物投与デバイス
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
DE10211832A1 (de) 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
TW200404581A (en) 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
AR033748A1 (es) 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
US6896655B2 (en) * 2002-08-05 2005-05-24 Eastman Kodak Company System and method for conditioning the psychological state of a subject using an adaptive autostereoscopic display
EP1682102A2 (en) 2003-09-10 2006-07-26 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
US20050202073A1 (en) 2004-03-09 2005-09-15 Mylan Technologies, Inc. Transdermal systems containing multilayer adhesive matrices to modify drug delivery

Also Published As

Publication number Publication date
BRPI0921040A2 (pt) 2015-12-29
KR20110132548A (ko) 2011-12-08
AU2009313744A1 (en) 2010-05-20
CA2743901A1 (en) 2010-05-20
US20120078204A1 (en) 2012-03-29
JP2014196327A (ja) 2014-10-16
EP2373300A4 (en) 2012-09-19
US20090142390A1 (en) 2009-06-04
EP2373300A1 (en) 2011-10-12
CN102281874A (zh) 2011-12-14
MX2011005183A (es) 2011-10-28
US9198877B2 (en) 2015-12-01
WO2010057189A1 (en) 2010-05-20
KR101716909B1 (ko) 2017-03-15
US9205062B2 (en) 2015-12-08
JP2012509276A (ja) 2012-04-19

Similar Documents

Publication Publication Date Title
BRPI0921040A8 (pt) sistemas transdérmicos contendo matrizes adesivas em multicamadas para modificar a liberação de fármacos
IL283459B (en) Novel lipids and compositions for the delivery of therapeutics
DK2219603T3 (da) Transdermalt afgivelsessystem
PL2361175T3 (pl) Sposób wytwarzania systemu dozowania materiału
BRPI0917549A2 (pt) dispositivo para a liberação de um medicamento
BRPI0817907A8 (pt) aparelho para administrar uma substância a um indivíduo
BRPI0922949A2 (pt) unidade de recarga para um distribuidor de produto, e, distribuidor
EP2540288A4 (en) SKIN PATCH
BRPI0817631A2 (pt) Dispositivo para adicionar um medicamento a uma solução de infusão em um recipiente de infusão
BRPI0906979A2 (pt) Mídia composta para etnrega a um aplicativo de cliente
DK2296732T3 (da) Medikamentafgivelsesindretning
EP2255809A4 (en) PLASTER WITH MEDICAMENT PLASTER
EP2299989A4 (en) STERILIZED TRANSDERMAL DRUG DELIVERY SYSTEM
BRDI7004545S (pt) Configuração aplicada a um calçado
EP2303394A4 (en) DEVICE FOR TRANSDERMAL ADMINISTRATIONS
EP2336260A4 (en) laminating
SI1737406T2 (sl) Transdermalni sistemi vsebujoči večplastne lepljive matrike za modifikacijo aplikacije zdravila
PL3023120T3 (pl) Aparaty do podawania leków przez skórę
DOS2008000078S (es) Dispositivos para aplicar betun al calzado
EP2343979A4 (en) TRANSDERMALE ADMINISTRATION
LT3766876T (lt) Farmacinė vaisto forma, turinti chinolono darinį
BRPI0920522A2 (pt) embalagem para administração de fármaco iontoforético
DK3202420T3 (da) Transdermale farmaceutiske sammensætninger omfattende en serm
BRPI0813689A2 (pt) Profármacos de aminoacila como substância ativa medicamentosa para doenças tramboembólicas
BRPI0814979A2 (pt) Composição terapêutica aromatizada contendo uma argila como princípio ativo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B07A Technical examination (opinion): publication of technical examination (opinion)
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: A61K 9/70

Ipc: A61K 9/70 (2006.01), A61K 31/567 (2006.01), A61K 3

B09B Decision: refusal
B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL